Terrosa (Teriparatide)

teriparatide 250 microgram/mL injection, 2.4 mL pen device · INJECTION · PBS code 14482F

STREAMLINED

What it costs

AU$149.55 PBS-determined price per 2 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2024-09-01.
• Repeats: 2.
• PBS program: GE.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Severe established osteoporosis

Continuing treatment

The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND

Patient must have previously been issued with an authority prescription for this drug; AND

The treatment must not exceed a lifetime maximum of 18 months therapy; AND

Must be treated by a specialist; or

Must be treated by a consultant physician.

Sponsor: Gedeon Richter Australia Pty Ltd ABN 98 602 550 274

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.